Neuroem Therapeutics, INC.
At a glance
EmployeesNot reported
In business sinceNot reported
HeadquartersTampa, FL
US patents7
SAM.gov UEICNRKB4K64ND5
CAGE code6ZJ35
Incorporated inDE
- neuromodulation
- TEMT-RF
- Breakthrough Device status
- treatment
Named on the company’s own website, read SEP 9, 2026
Patents
7 US patents granted 2020–2025, 6 of them in the five years to SEP 2025.
Medical technology 7
- Brain immunoregulation through transcranial electromagnetic treatmentUS 12,318,624 · granted JUN 3, 2025
- Treatment of primary and metastatic brain cancers by transcranial electromagnetic treatmentUS 11,911,629 · granted FEB 27, 2024
- Systems for sensing proper emitter array placementUS 11,813,472 · granted NOV 14, 2023
- Transcranial electromagnetic treatmentUS 11,794,028 · granted OCT 24, 2023
- Immunoregulation, brain detoxification, and cognitive protection by electromagnetic treatmentUS 11,759,650 · granted SEP 19, 2023
Newest 5 shown · Granted to NeuroEM Therapeutics, Inc. · PatentsView (USPTO), data through SEP 30, 2025 · CC BY 4.0
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Neuroem Therapeutics, INC. | Tampa | FL | — | ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.